Actinogen Medical Limited 3AC.F Stock
Actinogen Medical Limited Price Chart
Actinogen Medical Limited 3AC.F Financial and Trading Overview
| Actinogen Medical Limited stock price | 0.02 EUR |
| Previous Close | 0.02 EUR |
| Open | 0.02 EUR |
| Bid | 0.02 EUR x 4666700 |
| Ask | 0.04 EUR x 3750000 |
| Day's Range | 0.02 - 0.02 EUR |
| 52 Week Range | 0.02 - 0.1 EUR |
| Volume | 1K EUR |
| Avg. Volume | 17 EUR |
| Market Cap | 52.42M EUR |
| Beta (5Y Monthly) | 2.170498 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
3AC.F Valuation Measures
| Enterprise Value | 15.45M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.287187 |
| Price/Book (mrq) | 1.7222222 |
| Enterprise Value/Revenue | 3.326 |
| Enterprise Value/EBITDA | -1.418 |
Trading Information
Actinogen Medical Limited Stock Price History
| Beta (5Y Monthly) | 2.170498 |
| 52-Week Change | -23.25% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.1 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.02 EUR |
| 200-Day Moving Average | 0.04 EUR |
3AC.F Share Statistics
| Avg. Volume (3 month) | 17 EUR |
| Avg. Daily Volume (10-Days) | 100 EUR |
| Shares Outstanding | 1.81B |
| Float | 1.27B |
| Short Ratio | N/A |
| % Held by Insiders | 19.57% |
| % Held by Institutions | 14.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -239.89% |
| Operating Margin (ttm) | -241.43% |
| Gross Margin | 100.00% |
| EBITDA Margin | -234.53% |
Management Effectiveness
| Return on Assets (ttm) | -32.23% |
| Return on Equity (ttm) | -54.81% |
Income Statement
| Revenue (ttm) | 4.64M EUR |
| Revenue Per Share (ttm) | 0.003 EUR |
| Quarterly Revenue Growth (yoy) | 3732.80% |
| Gross Profit (ttm) | 3.64M EUR |
| EBITDA | -10892271 EUR |
| Net Income Avi to Common (ttm) | -11141158 EUR |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.48M EUR |
| Total Cash Per Share (mrq) | 0.008 EUR |
| Total Debt (mrq) | 126.75K EUR |
| Total Debt/Equity (mrq) | 0.79 EUR |
| Current Ratio (mrq) | 8.85 |
| Book Value Per Share (mrq) | 0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8577689 EUR |
| Levered Free Cash Flow (ttm) | -4539694 EUR |
Profile of Actinogen Medical Limited
| Country | Germany |
| State | NSW |
| City | Sydney |
| Address | 109 Pitt Street |
| ZIP | 2000 |
| Phone | 61 2 8964 7401 |
| Website | https://www.actinogen.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Q&A For Actinogen Medical Limited Stock
What is a current 3AC.F stock price?
Actinogen Medical Limited 3AC.F stock price today per share is 0.02 EUR.
How to purchase Actinogen Medical Limited stock?
You can buy 3AC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Actinogen Medical Limited?
The stock symbol or ticker of Actinogen Medical Limited is 3AC.F.
Which industry does the Actinogen Medical Limited company belong to?
The Actinogen Medical Limited industry is Biotechnology.
How many shares does Actinogen Medical Limited have in circulation?
The max supply of Actinogen Medical Limited shares is 2.46B.
What is Actinogen Medical Limited Price to Earnings Ratio (PE Ratio)?
Actinogen Medical Limited PE Ratio is now.
What was Actinogen Medical Limited earnings per share over the trailing 12 months (TTM)?
Actinogen Medical Limited EPS is 0 EUR over the trailing 12 months.
Which sector does the Actinogen Medical Limited company belong to?
The Actinogen Medical Limited sector is Healthcare.